Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Recent signings

FYI-From the 5/12/08 Letter from RG - verbatim



While all licensees to date have chosen lump sum front-end buy-outs, TPL continues to offer an on-going royalty payment option in new customer agreements and future license agreements could include on-going royalties.

Share
New Message
Please login to post a reply